Clinical Trial Update: Altreno for Chest Rejuvenation [Phase 4]

View source ↗

Summary

Phase 4 trial update for Altreno addressing photodamaged skin and photoaging; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photoaging
• Photodamaged Skin

Drugs mentioned

• ALTRENO (TRETINOIN)

Snippet

Sponsor: Goldman, Butterwick, Fitzpatrick and Groff | Conditions: Photodamaged Skin, Photoaging | Phase 4 | Status: UNKNOWN